NWPF

News ArchivesRead News

Brain Inflammation Linked to Greater Complications in Parkinson's Disease

Wednesday August 28, 2013

Kathleen Lees

Science World Report - A recent study looks at brain inflammation and the increasing problem involving fluid in the brain's cortex and complications with Parkinson's disease.

According to researcher Lena Brudin of Michigan State University's College of Human Medicine who was part of a research team that measured inflammatory markers involving cerebrospinal fluid samples of Parkinson's patients and members of the control group, inflammation caused significantly more problems when relating to the disease.

"The degree of neuroinflammation was significantly associated with more severe depression, fatigue and cognitive impairment even after controlling for factors such as age, gender and disease duration," Brundin said, an associate professor in the college and a researcher with the Van Andel Institute, via a press release. "By investigating associations between inflammatory markers and non-motor symptoms we hope to gain further insights into this area, which in turn could lead to new treatment options."

Researchers have long believed that brain inflammation is the suspected cause of Parkinson's disease and can specifically cause depression, fatigue and cognitive impairment. Recent research also suggests that inflammation could drive cell death and prevent the development of new drugs that may halt the progression of the health issue.

As Parkinson's is the second most common degenerative disorder of the central nervous system, many causes surrounding the disorder are not yet fully understood.

The study looked at 87 Parkinson's patients who were enrolled between 2008 and 2012. The control group consisted of 37 individuals who were recruited and underwent a physical exam and routine blood screen. Researcher also looked at the following markers, according to the study: C-reactive protein, interleukin-6, tumor necrosis factor-alpha, eotaxin, interferon gamma-induced protein-10, monocyte chemotactic protein-1 and macrophage inflammatory protein 1-B.

More information regarding the study can be found via the journal Brain, Behavior and Immunity.

Lees, K. (28 Aug 2013). Science World Report. Brain Inflammation Linked to Greater Complications in Parkinson's Disease. www.scienceworldreport.com

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression